The U.S. Food and Drug Administration (FDA) has granted an expanded interchangeable designation for Celltrion’s YUFLYMA.

The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and ...

The Global Prefilled Syringes Market is expected to witness a high single-digit growth rate by 2027. The growth of the prefilled syringes market is driven by an increasing prevalence of diverse ...

Selarsdi’s approved presentations include a subcutaneous injection with 45mg/0.5ml and 90mg/ml in a single-dose prefilled syringe ... a proposed biosimilar for Simponi (golimumab) and Simponi ...

Approved presentations of SELARSDI are 45 mg/0.5 mL and 90 mg/mL in a single-dose prefilled syringe for subcutaneous ... a proposed biosimilar for Simponi® (golimumab) and Simponi Aria ...

Udenyca gives patients options with 3 different ways to take it — an autoinjector, an on-body injector, or a prefilled syringe — so they can get ... 4 The biosimilar referencing Simponi (golimumab) is ...

FDA approved Vyvgart Hytrulo prefilled syringe for gMG and CIDP self-injection in 20–30 seconds. Human factor studies showed patients and caregivers safely administered the new formulation.

“We understand patients experience MG and CIDP in different ways, and our prefilled syringe is an important innovation that provides patients with more freedom and flexibility to self-administer ...

The global market for prefilled syringes is expanding, driven by the rising prevalence of chronic illnesses, greater use of biologics and biosimilars, and a growing trend toward self-injection.

The new single-dose prefilled syringes will be available in 40 USP units/0.5mL and 80 USP units/mL dosage strengths. The Food and Drug Administration (FDA) has approved Purified Cortrophin ® Gel ...

The new prefilled syringe has the same composition but removes the need for reconstitution. The Food and Drug Administration (FDA) has accepted for review the regulatory application for a new ...

Golimumab Simponi (Janssen) SC (autoinjector or pre-filled syringe) 1 ml, 100 mg/ml Wk 0: 2 × 100 mg inj Risinkizumab Skyrizi (AbbVie) IV, SC (pre-filled pen) IV: 10 or 20 ml, 60 mg/ml SC: 1.2 or 2.4 ...